Sales 2024 * | 55.14B 50.65B | Sales 2025 * | 58.11B 53.38B | Capitalization | 289B 266B |
---|---|---|---|---|---|
Net income 2024 * | 7.74B 7.11B | Net income 2025 * | 10.64B 9.78B | EV / Sales 2024 * | 6.22 x |
Net Debt 2024 * | 53.62B 49.25B | Net Debt 2025 * | 47.29B 43.44B | EV / Sales 2025 * | 5.79 x |
P/E ratio 2024 * |
31.8
x | P/E ratio 2025 * |
24.4
x | Employees | - |
Yield 2024 * |
3.78% | Yield 2025 * |
3.97% | Free-Float | 96.37% |
Latest transcript on AbbVie
Managers | Title | Age | Since |
---|---|---|---|
Richard Gonzalez
CEO | Chief Executive Officer | 70 | 12-12-31 |
Scott Reents
DFI | Director of Finance/CFO | 57 | 12-12-31 |
Robert Michael
PSD | President | 53 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 63 | 12-12-31 |
Edward Rapp
BRD | Director/Board Member | 66 | 12-12-31 |
Director/Board Member | 70 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B | |
+0.89% | 124B |